Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia

New England Journal of Medicine

Volumn 377, Issue 24, 2017, Pages 2399-2400

  Sentilhes, Loïc ^a   Azria, Elie ^b   Schmitz, Thomas ^c  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b SAINT JOSEPH HOSPITAL   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; PLACEBO; ANTITHROMBOCYTIC AGENT;

CLINICAL OUTCOME; COST EFFECTIVENESS ANALYSIS; FALSE POSITIVE RESULT; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HOSPITALIZATION; HUMAN; LETTER; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; FEMALE; NEWBORN; PREGNANCY; RISK; HYPERTENSION;

ASPIRIN; FEMALE; HUMANS; INFANT, NEWBORN; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREGNANCY; RISK; HYPERTENSION;

EID: 85038416233     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1713798     Document Type: Letter

References (1)

1. Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017; 377: 613-22.